INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
SEC FORM 4/Grant or awardVerified data

Foust Warren reported STAA

Interim Co-CEO and Pres. & COO · STAAR SURGICAL CO · STAAR SURGICAL CO — Restricted Stock Units

Side
A
Value
—
Shares
45.1K
Price
—
Executed
Mar 13, 2026
Disclosed
Mar 16, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Mar 13 executedMar 16, 2026 disclosed

STAA · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · STAA

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    ZY
    Zhou Lilian YanshengDirector
    STAASTAAR SURGICAL CO
    Grant or award
    		A—
    3,091 sh
    		Jun 18, 2026Jun 22, 2026
    traded Jun 18, 2026
    		+4dSEC FORM 4

    Evidence

    9
    ZY
    Zhou Lilian YanshengDirector
    STAASTAAR SURGICAL CO
    Grant or award
    		A—
    5,572 sh
    		Jun 18, 2026Jun 22, 2026
    traded Jun 18, 2026
    		+4dSEC FORM 4

    Evidence

    9
    JW
    Jiang WeiDirector
    STAASTAAR SURGICAL CO
    Grant or award
    		A—
    6,182 sh
    		Jun 18, 2026Jun 22, 2026
    traded Jun 18, 2026
    		+4dSEC FORM 4

    Evidence

    13
    JW
    Jiang WeiDirector
    STAASTAAR SURGICAL CO
    Option exercise
    		M—
    10.7K sh
    		Jun 18, 2026Jun 22, 2026
    traded Jun 18, 2026
    		+4dSEC FORM 4

    Evidence

    9
    JW
    Jiang WeiDirector
    STAASTAAR SURGICAL CO
    Option exercise
    		M—
    10.7K sh
    		Jun 18, 2026Jun 22, 2026
    traded Jun 18, 2026
    		+4dSEC FORM 4

    Evidence

    16
    FW
    Foust WarrenInterim Co-CEO and Pres. & COO
    STAASTAAR SURGICAL CO
    Tax withholding
    		F$92K
    3,448 sh
    		May 8, 2026May 12, 2026
    traded May 8, 2026
    		+4dSEC FORM 4

    Evidence

    17
    FW
    Foust WarrenInterim Co-CEO and Pres. & COO
    STAASTAAR SURGICAL CO
    Option exercise
    		M—
    8,175 sh
    		Mar 12, 2026Mar 16, 2026
    traded Mar 12, 2026
    		+4dSEC FORM 4

    Evidence

    21
    FW
    Foust WarrenInterim Co-CEO and Pres. & COO
    STAASTAAR SURGICAL CO
    Option exercise
    		M—
    19.6K sh
    		Mar 14, 2026Mar 16, 2026
    traded Mar 14, 2026
    		+2dSEC FORM 4

    Evidence

    13
    FW
    Foust WarrenInterim Co-CEO and Pres. & COO
    STAASTAAR SURGICAL CO
    Option exercise
    		M—
    9,775 sh
    		Mar 14, 2026Mar 16, 2026
    traded Mar 14, 2026
    		+2dSEC FORM 4

    Evidence

    9
    FW
    Foust WarrenInterim Co-CEO and Pres. & COO
    STAASTAAR SURGICAL CO
    Option exercise
    		M—
    8,175 sh
    		Mar 12, 2026Mar 16, 2026
    traded Mar 12, 2026
    		+4dSEC FORM 4

    Evidence

    21
    FW
    Foust WarrenInterim Co-CEO and Pres. & COO
    STAASTAAR SURGICAL CO
    Option exercise
    		M—
    19.6K sh
    		Mar 14, 2026Mar 16, 2026
    traded Mar 14, 2026
    		+2dSEC FORM 4

    Evidence

    21
    FW
    Foust WarrenInterim Co-CEO and Pres. & COO
    STAASTAAR SURGICAL CO
    Option exercise
    		M—
    9,775 sh
    		Mar 14, 2026Mar 16, 2026
    traded Mar 14, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001970778-26-000003
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Mar 13, 2026
    Published
    Mar 16, 2026
    Ingested by INSIDER
    Nov 5, 04:11 UTC
    Last re-read
    Nov 5, 04:11 UTC

    Extracted facts

    Filer
    Foust Warren
    Role
    Interim Co-CEO and Pres. & COO
    Transaction
    Grant or awardAs filed: “A”
    Asset
    STAAR SURGICAL CO — Restricted Stock Units
    Ticker
    STAA
    Shares
    45.1K
    Price per share
    $0
    Execution date (reported)
    Mar 13, 2026
    Owned after transaction
    45.1K shares
    Days from execution to publication
    3

    What this establishes

    Foust Warren filed this Form 4 reporting a grant or award of STAA on Mar 13, 2026. It became public on Mar 16, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Interim Co-CEO and Pres. & COO
    Foust Warrencik:0001970778
    Issuer
    STAAR SURGICAL COcik:0000718937

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.

    Source error

    Price history for STAA is unavailable.

    An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.